An Interview With Drs. Christine Cliatt Brown and Heather Nelson: Diagnostic Testing and Therapeutics Making a Difference for Patients With Alzheimer’s Disease
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
An Interview With Drs. Christine Cliatt Brown and Heather Nelson: Diagnostic Testing and Therapeutics Making a Difference for Patients With Alzheimer’s Disease
-
Narrado por:
-
De:
New blood-based tests for Alzheimer's disease (AD) are advancing and reshaping how this devastating disorder is detected and treated. In this episode, Dr. Christine Cliatt Brown, assistant professor in the division of Cognitive Neurology at the University of Utah, and Dr. Heather Nelson, assistant professor in the department of Pathology at the University of Utah and medical director of Clinical Chemistry and Mass Spectrometry at ARUP Laboratories, discuss how emerging diagnostics are transforming the diagnosis and management of AD. Together, they explore how collaboration across clinical and laboratory disciplines can accelerate diagnostic innovation and support advances in patient care.
Related Information: Plasma-Based Diagnostics for Alzheimer’s Disease: Current State and Clinical Relevance of pTau 217 [aruplab.com/pTau217-2026]